← Top Holdings
BBIOBRIDGEBIO PHARMA INC
CUSIP: 10806X102
3
Guru Owners
$1.11B
Total Value Held
14.5M
Total Shares
| Investor | Fund | Shares | Value▼ | % of Portfolio | Rpt Price | Period |
|---|---|---|---|---|---|---|
| Viking Global Investors | 14393934 | $1.10B | 2.92% | $76.49 | Q4 2025 | |
| Bridgewater Associates | 43172 | $3.3M | 0.01% | $76.49 | Q4 2025 | |
| Polen Capital Management | 38241 | $2.9M | 0.01% | $76.49 | Q4 2025 |
📊 Fundamentals
Market Cap$14.7B
Forward P/E368.2x
EPS (TTM)$-3.78
Revenue (TTM)$502.1M
Profit Margin-144.39%
Beta1.09
52-Week Range
$31.77
$84.94
Current: $75.84
Data from Yahoo Finance · refreshed every 4 hours
📊 Holdings Over Time
How superinvestor ownership has changed across quarters
Quarter-by-Quarter Activity
Q4 '253 owners · $1.11B
Q3 '252 owners · $831.8M
Q2 '252 owners · $802.8M
Q1 '252 owners · $777.6M
Q4 '241 owners · $689.3M
No changes
Q3 '241 owners · $639.6M
No changes
💰 DCF Calculator
DCF model · 10-yr forecastEstimates depend entirely on your assumptions. Adjust the inputs below to explore scenarios.
⚠️ This company currently has negative free cash flow. The valuation assumes it will improve.
📊 Adjust the assumptions below to calculate an estimated fair value
Projection Period
Revenue Growth Rate
73%analyst est. 73.3%
0%100%
Growth Decay Rate
15%
0% (no decay)50% (fast decay)
Terminal Growth Rate
3.0%
0%5%
FCF Margin
5.0%current: -64.8%
1%50%
Discount Rate (WACC)
8.0%typical: 8% large caps · 10% growth
5%20%
Model: 10-year DCF · 3.0% terminal growth · Based on Yahoo Finance data
🏛️ Congressional Trades
BBIO: Held by 3 superinvestors · 1 congress member trade
$1,001 - $15,0002025-08-08